Interestingly, the expression levels of MYC-target genes were significantly reduced after genetic and pharmaceutical ablation of PRMT1 (Fig. 5b, Supplementary Fig. 5c, d, h), which was consistent with previous reports depicting MYC as a suppressor of anti-tumor immunity42,43. This evidence concerns the gene PRMT1 and neoplasm.